The All-Russia GMP Conference has been held since 2016 and annually brings together leading international and Russian experts in the pharmaceutical industry, government representatives, managers and specialists of pharmaceutical companies, representatives of professional associations and communities, experts in the field of Quality Management System and Good Manufacturing Practice (GMP).
The Conference is organized by the Ministry of Industry and Trade of the Russian Federation together with the «State Institute of Drugs and Good Practices».
Over the past years, representatives of the world pharmaceutical community from Russia, the USA, Austria, Spain, Croatia, Japan, Switzerland, Italy, Poland, Hungary, Romania, Mexico, the Great Britain, Cuba, Bulgaria, Kazakhstan, Kyrgyzstan, Germany, Brazil, Slovenia and other countries took part in the Conference.
Partners of the Conference are the largest Russian and international companies, leading industry publishers and professional communities.
Each year, the event takes place in a new region of Russia, which helps the organizers to demonstrate the best practices in various parts of the country, and the participants to get acquainted with the regional aspect of the organization of the healthcare system and medicines supply.
Establishment of the single EAEU market remains one of the most discussed topics in the context of good practices development. In this respect, the V All-Russian GMP Conference initiated a…
The list of important partners includes PRO.MED.CS Praha a.s., a leading Czech pharmaceutical company supplying its products to 26 countries. Mainly, it supplies its products to the Russian Federation, countries of the Central and Eastern Europe and the Middle East. The company has its own scientific and research base and specialises in the production of final dosage forms used to treat the digestive, cardiovascular and nervous systems. The main mission of the company, as PRO.MED.CS Praha a.s. sees it, is to provide patients with tested and safe drugs at a reasonable price.
Despite the fact that the coronavirus prevails in the media space, we should not forget that the risk of influenza infection is still here.
The All-Russian GMP Conference with international participation pays special attention to the development of innovations and advanced approaches to the organisation of pharmaceuticals and medical equipment production.
The COVID-19 pandemic has posed a number of challenges to the entire economy, state and society. The year 2020 is not an easy one also for the pharmaceutical industry that found itself in the epicentre of the fight against the pandemic. In this context, the V All-Russian GMP Conference participants will pay much attention to the matters of development in these new conditions.